Last 12 months
Inside the activity.
0 purchase rows · 51 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 12 |
| Dec 2025 | 0 | 11 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 13 |
| Jun 2026 | 0 | 12 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 31, 2024 Filed Aug 2, 2024 20:41 UTC |
DOSSETT JEFFREYCHIEF REVENUE OFFICER
|
SaleCommon Stock | 3,410 | $158.31 | $539,845.28 |
DisclosureSEC source: 0001415889-24-020636 · form4-08022024_080809.xml · nonDerivative · entry 4 DOSSETT JEFFREY · CIK 0001578147 · CHIEF REVENUE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 66,949 F1 · kind: The sales reported by Mr. Dossett were effected pursuant to a 10b5-1 trading plan effective May 1, 2024. F4 · price: This transaction was executed in multiple trades at prices ranging from $157.85 to $158.835. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. Read SEC document |
| July 31, 2024 Filed Aug 2, 2024 20:41 UTC |
DOSSETT JEFFREYCHIEF REVENUE OFFICER
|
SaleCommon Stock | 2,438 | $157.12 | $383,053.68 |
DisclosureSEC source: 0001415889-24-020636 · form4-08022024_080809.xml · nonDerivative · entry 3 DOSSETT JEFFREY · CIK 0001578147 · CHIEF REVENUE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 70,359 F1 · kind: The sales reported by Mr. Dossett were effected pursuant to a 10b5-1 trading plan effective May 1, 2024. F3 · price: This transaction was executed in multiple trades at prices ranging from $156.77 to $157.565. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. Read SEC document |
| July 31, 2024 Filed Aug 2, 2024 20:41 UTC |
DOSSETT JEFFREYCHIEF REVENUE OFFICER
|
SaleCommon Stock | 5,845 | $156.27 | $913,415.10 |
DisclosureSEC source: 0001415889-24-020636 · form4-08022024_080809.xml · nonDerivative · entry 2 DOSSETT JEFFREY · CIK 0001578147 · CHIEF REVENUE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 72,797 F1 · kind: The sales reported by Mr. Dossett were effected pursuant to a 10b5-1 trading plan effective May 1, 2024. F2 · price: This transaction was executed in multiple trades at prices ranging from $155.76 to $156.72. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. Read SEC document |
| July 31, 2024 Filed Aug 2, 2024 20:41 UTC |
DOSSETT JEFFREYCHIEF REVENUE OFFICER
|
Exercise / conversionCommon Stock | 15,000 | $17.33 | $259,950.00 |
DisclosureSEC source: 0001415889-24-020636 · form4-08022024_080809.xml · nonDerivative · entry 1 DOSSETT JEFFREY · CIK 0001578147 · CHIEF REVENUE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 78,642 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 15, 2024 Filed Jul 16, 2024 21:38 UTC |
MECKLAI HUSSEINCHIEF OPERATING OFFICER
|
SaleCommon Stock | 40 | $176.91 | $7,076.40 |
DisclosureSEC source: 0001415889-24-019602 · form4-07162024_090740.xml · nonDerivative · entry 4 MECKLAI HUSSEIN · CIK 0001908089 · CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,104 F1 · kind: These shares were disposed of in non-discretionary transactions to cover the reporting person's tax withholding obligations in connection with the settlement of an award of restricted stock units ("RSUs"). Read SEC document |
| July 15, 2024 Filed Jul 16, 2024 21:38 UTC |
MECKLAI HUSSEINCHIEF OPERATING OFFICER
|
SaleCommon Stock | 106 | $175.96 | $18,651.92 |
DisclosureSEC source: 0001415889-24-019602 · form4-07162024_090740.xml · nonDerivative · entry 3 MECKLAI HUSSEIN · CIK 0001908089 · CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,144 F1 · kind: These shares were disposed of in non-discretionary transactions to cover the reporting person's tax withholding obligations in connection with the settlement of an award of restricted stock units ("RSUs"). F3 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $175.60 to $176.36, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| July 15, 2024 Filed Jul 16, 2024 21:38 UTC |
MECKLAI HUSSEINCHIEF OPERATING OFFICER
|
SaleCommon Stock | 270 | $175.01 | $47,251.43 |
DisclosureSEC source: 0001415889-24-019602 · form4-07162024_090740.xml · nonDerivative · entry 2 MECKLAI HUSSEIN · CIK 0001908089 · CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,250 F1 · kind: These shares were disposed of in non-discretionary transactions to cover the reporting person's tax withholding obligations in connection with the settlement of an award of restricted stock units ("RSUs"). F2 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $174.55 to $175.41, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| July 15, 2024 Filed Jul 16, 2024 21:37 UTC |
DOSSETT JEFFREYCHIEF REVENUE OFFICER
|
SaleCommon Stock | 40 | $176.67 | $7,066.60 |
DisclosureSEC source: 0001415889-24-019601 · form4-07162024_090726.xml · nonDerivative · entry 4 DOSSETT JEFFREY · CIK 0001578147 · CHIEF REVENUE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,642 F1 · kind: These shares were disposed of in non-discretionary transactions to cover the reporting person's tax withholding obligations in connection with the settlement of an award of restricted stock units ("RSUs"). Read SEC document |
| July 15, 2024 Filed Jul 16, 2024 21:37 UTC |
DOSSETT JEFFREYCHIEF REVENUE OFFICER
|
SaleCommon Stock | 115 | $175.87 | $20,225.10 |
DisclosureSEC source: 0001415889-24-019601 · form4-07162024_090726.xml · nonDerivative · entry 3 DOSSETT JEFFREY · CIK 0001578147 · CHIEF REVENUE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,682 F1 · kind: These shares were disposed of in non-discretionary transactions to cover the reporting person's tax withholding obligations in connection with the settlement of an award of restricted stock units ("RSUs"). F3 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $175.57 to $176.24, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| July 15, 2024 Filed Jul 16, 2024 21:37 UTC |
DOSSETT JEFFREYCHIEF REVENUE OFFICER
|
SaleCommon Stock | 320 | $175.05 | $56,014.98 |
DisclosureSEC source: 0001415889-24-019601 · form4-07162024_090726.xml · nonDerivative · entry 2 DOSSETT JEFFREY · CIK 0001578147 · CHIEF REVENUE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,797 F1 · kind: These shares were disposed of in non-discretionary transactions to cover the reporting person's tax withholding obligations in connection with the settlement of an award of restricted stock units ("RSUs"). F2 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $174.55 to $175.49, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| July 15, 2024 Filed Jul 16, 2024 21:34 UTC |
DIORIO CHRIS PH.D.Director · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 96 | $176.70 | $16,962.72 |
DisclosureSEC source: 0001415889-24-019597 · form4-07162024_090704.xml · nonDerivative · entry 4 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 291,412 F1 · kind: These shares were disposed of in non-discretionary transactions to cover the reporting person's tax withholding obligations in connection with the settlement of an award of restricted stock units ("RSUs"). Read SEC document |
| July 15, 2024 Filed Jul 16, 2024 21:34 UTC |
DIORIO CHRIS PH.D.Director · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 296 | $176.03 | $52,104.29 |
DisclosureSEC source: 0001415889-24-019597 · form4-07162024_090704.xml · nonDerivative · entry 3 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 291,508 F1 · kind: These shares were disposed of in non-discretionary transactions to cover the reporting person's tax withholding obligations in connection with the settlement of an award of restricted stock units ("RSUs"). F3 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $175.59 to $176.36, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| July 15, 2024 Filed Jul 16, 2024 21:34 UTC |
DIORIO CHRIS PH.D.Director · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 795 | $175.05 | $139,166.90 |
DisclosureSEC source: 0001415889-24-019597 · form4-07162024_090704.xml · nonDerivative · entry 2 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 291,804 F1 · kind: These shares were disposed of in non-discretionary transactions to cover the reporting person's tax withholding obligations in connection with the settlement of an award of restricted stock units ("RSUs"). F2 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $174.555 to $175.42, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| July 15, 2024 Filed Jul 16, 2024 21:35 UTC |
Baker CaryCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 42 | $176.65 | $7,419.28 |
DisclosureSEC source: 0001415889-24-019599 · form4-07162024_090743.xml · nonDerivative · entry 4 Baker Cary · CIK 0001705407 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,760 F1 · kind: These shares were disposed of in non-discretionary transactions to cover the reporting person's tax withholding obligations in connection with the settlement of an award of restricted stock units ("RSUs"). F4 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $176.64 to $176.68, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| July 15, 2024 Filed Jul 16, 2024 21:35 UTC |
Baker CaryCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 122 | $175.83 | $21,451.03 |
DisclosureSEC source: 0001415889-24-019599 · form4-07162024_090743.xml · nonDerivative · entry 3 Baker Cary · CIK 0001705407 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,802 F1 · kind: These shares were disposed of in non-discretionary transactions to cover the reporting person's tax withholding obligations in connection with the settlement of an award of restricted stock units ("RSUs"). F3 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $175.575 to $176.31, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| July 15, 2024 Filed Jul 16, 2024 21:35 UTC |
Baker CaryCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 192 | $174.89 | $33,578.09 |
DisclosureSEC source: 0001415889-24-019599 · form4-07162024_090743.xml · nonDerivative · entry 2 Baker Cary · CIK 0001705407 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,924 F1 · kind: These shares were disposed of in non-discretionary transactions to cover the reporting person's tax withholding obligations in connection with the settlement of an award of restricted stock units ("RSUs"). F2 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $174.555 to $175.41, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| July 12, 2024 Filed Jul 16, 2024 21:38 UTC |
MECKLAI HUSSEINCHIEF OPERATING OFFICER
|
Exercise / conversionRestricted Stock Units · Derivative | 1,093 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-019602 · form4-07162024_090740.xml · derivative · entry 5 MECKLAI HUSSEIN · CIK 0001908089 · CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,282 Underlying: Common Stock · 1,093 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Impinj common stock. F5 · derivative.exercise_date: On April 12, 2021, the reporting person was granted 17,500 RSUs, one fourth of which vested on April 12, 2022, with an additional one-sixteenth of such RSUs vesting every three months thereafter. One-sixteenth of these RSUs vested on July 12, 2024. F5 · derivative.expiration_date: On April 12, 2021, the reporting person was granted 17,500 RSUs, one fourth of which vested on April 12, 2022, with an additional one-sixteenth of such RSUs vesting every three months thereafter. One-sixteenth of these RSUs vested on July 12, 2024. Read SEC document |
| July 12, 2024 Filed Jul 16, 2024 21:38 UTC |
MECKLAI HUSSEINCHIEF OPERATING OFFICER
|
Exercise / conversionCommon Stock | 1,093 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-019602 · form4-07162024_090740.xml · nonDerivative · entry 1 MECKLAI HUSSEIN · CIK 0001908089 · CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,520 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 12, 2024 Filed Jul 16, 2024 21:37 UTC |
DOSSETT JEFFREYCHIEF REVENUE OFFICER
|
Exercise / conversionRestricted Stock Units · Derivative | 1,250 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-019601 · form4-07162024_090726.xml · derivative · entry 5 DOSSETT JEFFREY · CIK 0001578147 · CHIEF REVENUE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,750 Underlying: Common Stock · 1,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Impinj common stock. F5 · derivative.exercise_date: On April 12, 2021, the reporting person was granted 20,000 RSUs, one fourth of which vested on April 12, 2022, with an additional one-sixteenth of such RSUs vesting every three months thereafter. One-sixteenth of these RSUs vested on July 12, 2024. F5 · derivative.expiration_date: On April 12, 2021, the reporting person was granted 20,000 RSUs, one fourth of which vested on April 12, 2022, with an additional one-sixteenth of such RSUs vesting every three months thereafter. One-sixteenth of these RSUs vested on July 12, 2024. Read SEC document |
| July 12, 2024 Filed Jul 16, 2024 21:37 UTC |
DOSSETT JEFFREYCHIEF REVENUE OFFICER
|
Exercise / conversionCommon Stock | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-019601 · form4-07162024_090726.xml · nonDerivative · entry 1 DOSSETT JEFFREY · CIK 0001578147 · CHIEF REVENUE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,117 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 12, 2024 Filed Jul 16, 2024 21:34 UTC |
DIORIO CHRIS PH.D.Director · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionRestricted Stock Units · Derivative | 3,125 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-019597 · form4-07162024_090704.xml · derivative · entry 6 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,375 Underlying: Common Stock · 3,125 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Impinj common stock. F5 · derivative.exercise_date: On April 12, 2021, the reporting person was granted 50,000 RSUs, one fourth of which vested on April 12, 2022, with an additional one-sixteenth of such RSUs vesting every three months thereafter. One-sixteenth of these RSUs vested on July 12, 2024. F5 · derivative.expiration_date: On April 12, 2021, the reporting person was granted 50,000 RSUs, one fourth of which vested on April 12, 2022, with an additional one-sixteenth of such RSUs vesting every three months thereafter. One-sixteenth of these RSUs vested on July 12, 2024. Read SEC document |
| July 12, 2024 Filed Jul 16, 2024 21:34 UTC |
DIORIO CHRIS PH.D.Director · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionCommon Stock | 3,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-019597 · form4-07162024_090704.xml · nonDerivative · entry 1 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 292,599 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 12, 2024 Filed Jul 16, 2024 21:35 UTC |
Baker CaryCHIEF FINANCIAL OFFICER
|
Exercise / conversionRestricted Stock Units · Derivative | 937 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-019599 · form4-07162024_090743.xml · derivative · entry 5 Baker Cary · CIK 0001705407 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,813 Underlying: Common Stock · 937 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Impinj common stock. F6 · derivative.exercise_date: On April 12, 2021, the reporting person was granted 15,000 RSUs, one fourth of which vested on April 12, 2022, with an additional one-sixteenth of such RSUs vesting every three months thereafter. One-sixteenth of these RSUs vested on July 12, 2024. F6 · derivative.expiration_date: On April 12, 2021, the reporting person was granted 15,000 RSUs, one fourth of which vested on April 12, 2022, with an additional one-sixteenth of such RSUs vesting every three months thereafter. One-sixteenth of these RSUs vested on July 12, 2024. Read SEC document |
| July 12, 2024 Filed Jul 16, 2024 21:35 UTC |
Baker CaryCHIEF FINANCIAL OFFICER
|
Exercise / conversionCommon Stock | 937 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-019599 · form4-07162024_090743.xml · nonDerivative · entry 1 Baker Cary · CIK 0001705407 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,116 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 08, 2024 Filed Jul 9, 2024 23:16 UTC |
DIORIO CHRIS PH.D.Director · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $22.40 | $0.00 |
DisclosureSEC source: 0001415889-24-019445 · form4-07092024_110755.xml · derivative · entry 6 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 75,536 Underlying: Common Stock · 5,000 shares Expires 2028-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option became fully vested on June 11, 2022. Read SEC document |
| July 08, 2024 Filed Jul 9, 2024 23:16 UTC |
DIORIO CHRIS PH.D.Director · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 522 | $163.16 | $85,167.07 |
DisclosureSEC source: 0001415889-24-019445 · form4-07092024_110755.xml · nonDerivative · entry 4 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 289,474 F1 · kind: The sales reported by Dr. Diorio were effected pursuant to a Rule 10b5-1 trading plan effective on February 28, 2024. F4 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $163.115 to $163.1825, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| July 08, 2024 Filed Jul 9, 2024 23:16 UTC |
DIORIO CHRIS PH.D.Director · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 2,981 | $162.50 | $484,427.11 |
DisclosureSEC source: 0001415889-24-019445 · form4-07092024_110755.xml · nonDerivative · entry 3 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 289,996 F1 · kind: The sales reported by Dr. Diorio were effected pursuant to a Rule 10b5-1 trading plan effective on February 28, 2024. F3 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $162.10 to $163.08, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| July 08, 2024 Filed Jul 9, 2024 23:16 UTC |
DIORIO CHRIS PH.D.Director · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 1,497 | $161.67 | $242,012.51 |
DisclosureSEC source: 0001415889-24-019445 · form4-07092024_110755.xml · nonDerivative · entry 2 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 292,977 F1 · kind: The sales reported by Dr. Diorio were effected pursuant to a Rule 10b5-1 trading plan effective on February 28, 2024. F2 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $161.0901 to $162.02, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| July 08, 2024 Filed Jul 9, 2024 23:16 UTC |
DIORIO CHRIS PH.D.Director · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionCommon Stock | 5,000 | $22.40 | $112,000.00 |
DisclosureSEC source: 0001415889-24-019445 · form4-07092024_110755.xml · nonDerivative · entry 1 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 294,474 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 02, 2024 Filed Jul 2, 2024 21:31 UTC |
DIORIO CHRIS PH.D.Director · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $22.40 | $0.00 |
DisclosureSEC source: 0001415889-24-018977 · form4-07022024_090747.xml · derivative · entry 14 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 80,536 Underlying: Common Stock · 5,000 shares Expires 2028-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: The option became fully vested on June 11, 2022. Read SEC document |
| July 02, 2024 Filed Jul 2, 2024 21:31 UTC |
DIORIO CHRIS PH.D.Director · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 350 | $156.34 | $54,719.00 |
DisclosureSEC source: 0001415889-24-018977 · form4-07022024_090747.xml · nonDerivative · entry 11 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 289,474 F1 · kind: The sales reported by Dr. Diorio were effected pursuant to a Rule 10b5-1 trading plan effective on February 28, 2024. Read SEC document |
| July 02, 2024 Filed Jul 2, 2024 21:31 UTC |
DIORIO CHRIS PH.D.Director · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 3,567 | $155.69 | $555,338.38 |
DisclosureSEC source: 0001415889-24-018977 · form4-07022024_090747.xml · nonDerivative · entry 10 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 289,824 F1 · kind: The sales reported by Dr. Diorio were effected pursuant to a Rule 10b5-1 trading plan effective on February 28, 2024. F9 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $155.25 to $156.245, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| July 02, 2024 Filed Jul 2, 2024 21:31 UTC |
DIORIO CHRIS PH.D.Director · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 1,083 | $154.55 | $167,376.03 |
DisclosureSEC source: 0001415889-24-018977 · form4-07022024_090747.xml · nonDerivative · entry 9 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 293,391 F1 · kind: The sales reported by Dr. Diorio were effected pursuant to a Rule 10b5-1 trading plan effective on February 28, 2024. F8 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $154.25 to $155.22, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| July 02, 2024 Filed Jul 2, 2024 21:31 UTC |
DIORIO CHRIS PH.D.Director · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionCommon Stock | 5,000 | $22.40 | $112,000.00 |
DisclosureSEC source: 0001415889-24-018977 · form4-07022024_090747.xml · nonDerivative · entry 8 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 294,474 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 21:31 UTC |
DIORIO CHRIS PH.D.Director · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $22.40 | $0.00 |
DisclosureSEC source: 0001415889-24-018977 · form4-07022024_090747.xml · derivative · entry 13 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 85,536 Underlying: Common Stock · 5,000 shares Expires 2028-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: The option became fully vested on June 11, 2022. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 21:31 UTC |
DIORIO CHRIS PH.D.Director · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 832 | $156.43 | $130,153.34 |
DisclosureSEC source: 0001415889-24-018977 · form4-07022024_090747.xml · nonDerivative · entry 7 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 289,474 F1 · kind: The sales reported by Dr. Diorio were effected pursuant to a Rule 10b5-1 trading plan effective on February 28, 2024. F7 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $156.32 to $156.6775, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 21:31 UTC |
DIORIO CHRIS PH.D.Director · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 1,093 | $155.55 | $170,020.52 |
DisclosureSEC source: 0001415889-24-018977 · form4-07022024_090747.xml · nonDerivative · entry 6 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 290,306 F1 · kind: The sales reported by Dr. Diorio were effected pursuant to a Rule 10b5-1 trading plan effective on February 28, 2024. F6 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $155.265 to $156.025, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 21:31 UTC |
DIORIO CHRIS PH.D.Director · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 409 | $154.66 | $63,257.78 |
DisclosureSEC source: 0001415889-24-018977 · form4-07022024_090747.xml · nonDerivative · entry 5 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 291,399 F1 · kind: The sales reported by Dr. Diorio were effected pursuant to a Rule 10b5-1 trading plan effective on February 28, 2024. F5 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $154.09 to $154.99, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 21:31 UTC |
DIORIO CHRIS PH.D.Director · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 1,385 | $153.37 | $212,422.30 |
DisclosureSEC source: 0001415889-24-018977 · form4-07022024_090747.xml · nonDerivative · entry 4 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 291,808 F1 · kind: The sales reported by Dr. Diorio were effected pursuant to a Rule 10b5-1 trading plan effective on February 28, 2024. F4 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $153.045 to $153.905, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 21:31 UTC |
DIORIO CHRIS PH.D.Director · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 392 | $152.25 | $59,683.29 |
DisclosureSEC source: 0001415889-24-018977 · form4-07022024_090747.xml · nonDerivative · entry 3 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 293,193 F1 · kind: The sales reported by Dr. Diorio were effected pursuant to a Rule 10b5-1 trading plan effective on February 28, 2024. F3 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $151.975 to $152.855, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 21:31 UTC |
DIORIO CHRIS PH.D.Director · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 889 | $151.40 | $134,597.71 |
DisclosureSEC source: 0001415889-24-018977 · form4-07022024_090747.xml · nonDerivative · entry 2 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 293,585 F1 · kind: The sales reported by Dr. Diorio were effected pursuant to a Rule 10b5-1 trading plan effective on February 28, 2024. F2 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $150.84 to $151.83, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 21:31 UTC |
DIORIO CHRIS PH.D.Director · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionCommon Stock | 5,000 | $22.40 | $112,000.00 |
DisclosureSEC source: 0001415889-24-018977 · form4-07022024_090747.xml · nonDerivative · entry 1 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 294,474 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 25, 2024 Filed Jun 25, 2024 23:12 UTC |
DIORIO CHRIS PH.D.Director · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $22.40 | $0.00 |
DisclosureSEC source: 0001415889-24-018171 · form4-06252024_110654.xml · derivative · entry 14 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 90,536 Underlying: Common Stock · 5,000 shares Expires 2028-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: The option became fully vested on June 11, 2022. Read SEC document |
| June 25, 2024 Filed Jun 25, 2024 23:12 UTC |
DIORIO CHRIS PH.D.Director · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 5,000 | $150.06 | $750,307.50 |
DisclosureSEC source: 0001415889-24-018171 · form4-06252024_110654.xml · nonDerivative · entry 9 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 289,474 F4 · kind: The sales reported by Dr. Diorio were effected pursuant to a Rule 10b5-1 trading plan effective on February 28, 2024. F7 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $150.00 to $150.155, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| June 25, 2024 Filed Jun 25, 2024 23:12 UTC |
DIORIO CHRIS PH.D.Director · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionCommon Stock | 5,000 | $22.40 | $112,000.00 |
DisclosureSEC source: 0001415889-24-018171 · form4-06252024_110654.xml · nonDerivative · entry 8 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 294,474 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 24, 2024 Filed Jun 25, 2024 23:19 UTC |
PHELAN CATHAL GDirector · CHIEF INNOVATION OFFICER
|
SaleCommon Stock | 56 | $148.29 | $8,303.97 |
DisclosureSEC source: 0001415889-24-018175 · form4-06252024_110647.xml · nonDerivative · entry 3 PHELAN CATHAL G · CIK 0001259761 · Director · CHIEF INNOVATION OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,669 F1 · kind: These shares were disposed of in non-discretionary transactions to cover the reporting person's tax withholding obligations in connection with the settlement of an award of restricted stock units. F3 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $148.04 to $148.59, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| June 24, 2024 Filed Jun 25, 2024 23:19 UTC |
PHELAN CATHAL GDirector · CHIEF INNOVATION OFFICER
|
SaleCommon Stock | 156 | $147.25 | $22,970.28 |
DisclosureSEC source: 0001415889-24-018175 · form4-06252024_110647.xml · nonDerivative · entry 2 PHELAN CATHAL G · CIK 0001259761 · Director · CHIEF INNOVATION OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,725 F1 · kind: These shares were disposed of in non-discretionary transactions to cover the reporting person's tax withholding obligations in connection with the settlement of an award of restricted stock units. F2 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $146.945 to $147.92 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| June 24, 2024 Filed Jun 25, 2024 23:18 UTC |
MECKLAI HUSSEINCHIEF OPERATING OFFICER
|
SaleCommon Stock | 303 | $148.23 | $44,913.17 |
DisclosureSEC source: 0001415889-24-018174 · form4-06252024_110616.xml · nonDerivative · entry 4 MECKLAI HUSSEIN · CIK 0001908089 · CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,427 F1 · kind: These shares were disposed of in non-discretionary transactions to cover the reporting person's tax withholding obligations in connection with the settlement of an award of restricted stock units ("RSUs"). F3 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $147.95 to $148.62, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| June 24, 2024 Filed Jun 25, 2024 23:18 UTC |
MECKLAI HUSSEINCHIEF OPERATING OFFICER
|
SaleCommon Stock | 530 | $147.21 | $78,019.55 |
DisclosureSEC source: 0001415889-24-018174 · form4-06252024_110616.xml · nonDerivative · entry 3 MECKLAI HUSSEIN · CIK 0001908089 · CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,730 F1 · kind: These shares were disposed of in non-discretionary transactions to cover the reporting person's tax withholding obligations in connection with the settlement of an award of restricted stock units ("RSUs"). F2 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $146.7401 to $147.68, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| June 24, 2024 Filed Jun 25, 2024 23:16 UTC |
DOSSETT JEFFREYCHIEF REVENUE OFFICER
|
SaleCommon Stock | 230 | $148.27 | $34,101.94 |
DisclosureSEC source: 0001415889-24-018173 · form4-06252024_110647.xml · nonDerivative · entry 4 DOSSETT JEFFREY · CIK 0001578147 · CHIEF REVENUE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,867 F1 · kind: These shares were disposed of in non-discretionary transactions to cover the reporting person's tax withholding obligations in connection with the settlement of an award of restricted stock units ("RSUs"). F3 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $147.98 to $148.83, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.